BYRN
HHS

KEARNES LAURILEE

Known title: Chief Financial OfficerCIK: 0001751130

KEARNES LAURILEE's purchase track record

How the stock did after each of KEARNES LAURILEE's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.

Purchases measured
4
of 5 since December 1, 2021
Stock higher 6 months later
100%
3 months: 50%
Median 6-month return
+25.3%
3 months: +38.8%
Beat the S&P 500
100%
median +30.6% vs. index
PurchaseStockAmount3 months6 months
7/22/2026BYRN$7Kpendingpending
11/15/2024BYRN$19K+79.0%+38.5%
10/10/2024BYRN$28K+91.9%+29.1%
5/11/2023HHS$10K-1.5%+21.4%
12/1/2021HHS$2K-13.9%+15.1%

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 28, 2026

Byrna Technologies to Report Q3 2026 Results on Oct 8. Byrna Technologies announced that it will release its fiscal third‑quarter 2026 financial results on Thursday, October 8, 2026 at 9:00 a.m. ET. The disclosure will provide the latest earnings and revenue figures for the company. The stock is currently near its $3.58 support level and has an RSI of about 38, suggesting limited momentum ahead of the report.

this person other insiders at BYRN
this person other insiders at HHS

Transaction History

BYRN▲ Buy$7K
BYRN▲ Buy—
BYRN▲ Buy—
BYRN▲ Buy—
BYRN▼ Sell$43K
BYRN▲ Buy$19K
BYRN▲ Buy$28K
HHS▼ Sell$50K
HHS▼ Sell$15K
HHS▼ Sell$6K
HHS▲ Buy$10K
HHS▼ Sell$25K
HHS▲ Buy—
HHS▼ Sell$101K
HHS▲ Buy—
HHS▼ Sell$31K
HHS▲ Buy—
HHS▼ Sell$56K
HHS▲ Buy$797
HHS▲ Buy$1K
HHS▲ Buy$40
HHS▲ Buy$8
HHS▼ Sell$12K
HHS▲ Buy$3K
HHS▲ Buy$126K

We use analytics to understand how market-wall is used. No personal data is sold.